Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000608688 | SCV000711086 | likely benign | not specified | 2016-07-05 | criteria provided, single submitter | clinical testing | p.Gly245Gly in exon 05 of KCNQ4: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 9/66470 European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs147751558). |
Gene |
RCV000841028 | SCV000982984 | likely benign | not provided | 2018-03-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000841028 | SCV001034415 | likely benign | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446172 | SCV004173186 | likely benign | Autosomal dominant nonsyndromic hearing loss 2A | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003980122 | SCV004786445 | likely benign | KCNQ4-related disorder | 2020-03-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |